Linagliptin
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
Year introduced: 2016 (2011)
PubMed search builder options
Subheadings:
Tree Number(s): D03.633.100.759.562, D03.633.100.786.563
MeSH Unique ID: D000069476
Registry Number: 3X29ZEJ4R2
Entry Terms:
- (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
- 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-
- BI 1356
- 1356, BI
- BI-1356
- BI1356
- Tradjenta
- Trajenta
See Also:
Pharmacologic Action: